Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
82 hedge funds and large institutions have $274M invested in Calithera Biosciences, Inc in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 14 closing their positions.
150% more capital invested
Capital invested by funds: $109M → $274M (+$164M)
81% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 21
4% less funds holding
Funds holding: 85 → 82 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
38% less call options, than puts
Call options by funds: $268K | Put options by funds: $430K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$35.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$10.6M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$1.86M |
| 4 |
Millennium Management
New York
|
+$809K |
| 5 |
Renaissance Technologies
New York
|
+$467K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.6M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.2M |
| 3 |
JP Morgan Chase
New York
|
-$795K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$730K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$424K |
CALA Hedge Fund Activity: Q4 2019 in Review
82 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2019, worth a combined $274M — up 150% from $109M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CALA and 11 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 38 added.
The largest buyer was Primecap Management, opening a new position worth an estimated $35.7M. The largest seller was Wellington Management Group, cutting an estimated $10.6M.
- 82 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2019, down from 85 in Q3 2019.
- Funds reported $274M of Calithera Biosciences, Inc stock for Q4 2019, up 150% quarter-over-quarter.
- 11 funds opened new Calithera Biosciences, Inc positions in Q4 2019 and 14 closed out, a net change of -3 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2019 was Primecap Management, an estimated $35.7M added.
- The largest Calithera Biosciences, Inc seller in Q4 2019 was Wellington Management Group, an estimated $10.6M sold.
Based on aggregated 13F filings for Q4 2019.